Find the perfect CRO

Whatever your needs, you'll find the perfect partner. BeCRO members share common values, amongst them high quality standards, responsiveness and essential human trust.

Spotlight

Live Webinar THE ‘SCHREMS II’ DECISION: IS IT STILL POSSIBLE TO EXCHANGE PERSONAL DATA FROM CLINICAL TRIALS BETWEEN EU AND US IN COMPLIANCE WITH GDPR: STATUS AND CONSEQUENCES - 28 Jan 2021

In July 2020, in the so-called “Schrems II” decision, the Court of Justice of the European Union declared the European Commission’s Privacy Shield Decision invalid, thereby making transfers of personal data on the basis of the Privacy Shield Decision illegal. Furthermore, the Court stipulated stricter requirements for the transfer of personal data based on standard contract clauses (SCCs).
During this interactive webinar, Hans Graux will explain more in detail this Schrems II decision, the consequences for the transfer of personal data between EU and US, the current status and an outlook for the future.

WHY BECOME A BECRO MEMBER?

Our latest news

GUIDANCE FOR SPONSORS ON THE USE OF ELECTRONIC INFORMED CONSENT IN INTERVENTIONAL CLINICAL TRIALS IN BELGIUM

On 30 September 2020, the Working group Informed Consent published version 1.0 of the guidance document on the use of e-consent in Belgium. Please find hereby the link to the document: https://overlegorganen.gezondheid.belgie.be/sites/default/files/content/guidance_on_use_of_e-icf_vf.pdf

Read More "GUIDANCE FOR SPONSORS ON THE USE OF ELECTRONIC INFORMED CONSENT IN INTERVENTIONAL CLINICAL TRIALS IN BELGIUM"

On 30th April, FAMHP published V2 of the Addendum to the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic

Please note that this document is to be read in conjunction with the latest version of the European guidance and that the national guidance provides some more detailed clarifications and additional topics of interest. This text was written by the FAMHP, the Clinical Trial College and the Belgian association of Research Ethics Committees (BAREC).The information […]

Read More "On 30th April, FAMHP published V2 of the Addendum to the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic"

Need more information ?

BECRO

PLACE MARCEL BROODTHAERS PLEIN, 8 BOX 5
B-1060 BRUSSELS / BELGIUM
PHONE: +32 (0)2 892 40 00
E-MAIL: INFO@BECRO.BE

© 2018 BECRO – ALL RIGHTS RESERVED

Octopix + WordPress = ♥ | Design by Simplexity